ReviewJournal of animal science and biotechnology2026
CRISPR-enhanced microalgae biosynthesis: a promising approach for future functional feed ingredients.
Review in Journal of animal science and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CRISPR-enhanced microalgae for carbon sequestration and carotenoid production: opportunities and fundamental constraints.Bioresources and bioprocessing · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Microalgae are photosynthetic microorganisms capable of synthesizing diverse high-value bioactive compounds, including premium proteins, polyunsaturated fatty acids, pigments, and vitamins. These natural products exhibit significant potential in enhancing livestock growth and health, offering biological activity and nutritional benefits that surpass chemically synthesized alternatives. Nevertheless, the commercial production of microalgae-derived natural products remains insufficient to meet escalating market demands. Utilizing synthetic biology strategies, especially the CRISPR system, to increase productivity of microalgae cell factories is crucial for scaling up high-value product biosynthesis. This article reviews the current applications, construction strategies, and critical pathway nodes in microalgae cell factory, with emphasis on CRISPR-based genome editing breakthroughs for optimizing microalgae nutritional profiles, and recent progress in microalgae utilization for livestock production, providing a forward-looking perspective on future developments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.